Last reviewed · How we verify

Dulcolax (Bisacodyl) — Competitive Intelligence Brief

Dulcolax (Bisacodyl) (Dulcolax (Bisacodyl)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Contact laxative. Area: Gastroenterology.

marketed Contact laxative Myenteric plexus; intestinal smooth muscle Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Dulcolax (Bisacodyl) (Dulcolax (Bisacodyl)) — Brooke Army Medical Center. Bisacodyl stimulates colonic muscle contractions and increases intestinal fluid secretion to promote bowel movements.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Dulcolax (Bisacodyl) TARGET Dulcolax (Bisacodyl) Brooke Army Medical Center marketed Contact laxative Myenteric plexus; intestinal smooth muscle
Bisacodyl 5 milligram Bisacodyl 5 milligram University of Nottingham marketed Contact laxative Colonic smooth muscle and intestinal epithelium

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Contact laxative class)

  1. Brooke Army Medical Center · 1 drug in this class
  2. University of Nottingham · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dulcolax (Bisacodyl) — Competitive Intelligence Brief. https://druglandscape.com/ci/dulcolax-bisacodyl. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: